Birgit Sehested Hansen

2.3k total citations
49 papers, 1.8k citations indexed

About

Birgit Sehested Hansen is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Endocrine and Autonomic Systems. According to data from OpenAlex, Birgit Sehested Hansen has authored 49 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Endocrinology, Diabetes and Metabolism, 14 papers in Molecular Biology and 14 papers in Endocrine and Autonomic Systems. Recurrent topics in Birgit Sehested Hansen's work include Growth Hormone and Insulin-like Growth Factors (18 papers), Regulation of Appetite and Obesity (14 papers) and Pancreatic function and diabetes (9 papers). Birgit Sehested Hansen is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (18 papers), Regulation of Appetite and Obesity (14 papers) and Pancreatic function and diabetes (9 papers). Birgit Sehested Hansen collaborates with scholars based in Denmark, United States and Germany. Birgit Sehested Hansen's co-authors include Michael Ankersen, Henning Thøgersen, Ger van Zandbergen, Helmut Laufs, Kerstin Müller, Werner Solbach, Tamás Laskay, Birgitte S. Wulff, Eresso Aga and Dörthe M. Katschinski and has published in prestigious journals such as The Journal of Immunology, The Journal of Clinical Endocrinology & Metabolism and Diabetes.

In The Last Decade

Birgit Sehested Hansen

49 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Birgit Sehested Hansen Denmark 23 536 350 332 298 243 49 1.8k
Glen E. Mott United States 26 575 1.1× 123 0.4× 226 0.7× 375 1.3× 168 0.7× 79 1.9k
Freek G. Bouwman Netherlands 31 1.2k 2.2× 183 0.5× 125 0.4× 788 2.6× 253 1.0× 105 2.8k
Ying He China 24 1.1k 2.0× 204 0.6× 133 0.4× 241 0.8× 92 0.4× 59 2.3k
Yue Yin China 20 715 1.3× 324 0.9× 216 0.7× 494 1.7× 57 0.2× 82 1.6k
J. T. Fleming United States 16 712 1.3× 131 0.4× 251 0.8× 394 1.3× 64 0.3× 26 2.3k
Candace M. Cham United States 17 1.4k 2.7× 308 0.9× 122 0.4× 667 2.2× 77 0.3× 24 2.7k
Kazuki Mochizuki Japan 26 2.0k 3.8× 127 0.4× 412 1.2× 503 1.7× 98 0.4× 159 3.3k
M. Pilar Lostao Spain 24 878 1.6× 202 0.6× 373 1.1× 267 0.9× 46 0.2× 69 2.0k
Guoyao Wu United States 28 781 1.5× 88 0.3× 161 0.5× 887 3.0× 129 0.5× 69 2.9k
Yu‐Cai Fu China 29 723 1.3× 104 0.3× 161 0.5× 665 2.2× 442 1.8× 66 2.4k

Countries citing papers authored by Birgit Sehested Hansen

Since Specialization
Citations

This map shows the geographic impact of Birgit Sehested Hansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birgit Sehested Hansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birgit Sehested Hansen more than expected).

Fields of papers citing papers by Birgit Sehested Hansen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Birgit Sehested Hansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birgit Sehested Hansen. The network helps show where Birgit Sehested Hansen may publish in the future.

Co-authorship network of co-authors of Birgit Sehested Hansen

This figure shows the co-authorship network connecting the top 25 collaborators of Birgit Sehested Hansen. A scholar is included among the top collaborators of Birgit Sehested Hansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Birgit Sehested Hansen. Birgit Sehested Hansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Speake, Cate, Henry T. Bahnson, Johnna D. Wesley, et al.. (2019). Systematic Assessment of Immune Marker Variation in Type 1 Diabetes: A Prospective Longitudinal Study. Frontiers in Immunology. 10. 2023–2023. 8 indexed citations
2.
Radford, Martha J., et al.. (2012). PDB46 Direct Medical Costs of Treating Diabetes Related Complications in Mexico. Value in Health. 15(4). A178–A179. 2 indexed citations
3.
Coppieters, Ken, Birgit Sehested Hansen, & Matthias G. von Herrath. (2012). Clinical Potential of Antigen-Specific Therapies in Type 1 Diabetes. The Review of Diabetic Studies. 9(4). 328–337. 4 indexed citations
4.
Conde‐Frieboes, Kilian W., Michael Ankersen, Jens Breinholt, et al.. (2011). Serendipitous discovery of a new class of agonists for the melanocortin 1 and 4 receptors and a new class of cyclophanes. Bioorganic & Medicinal Chemistry Letters. 21(5). 1459–1463. 6 indexed citations
5.
Hansen, Birgit Sehested. (2008). Insulin Analogues with Increased Mitogenic Potency - Are they Safe?. Hormone and Metabolic Research. 40(6). 431–433. 18 indexed citations
6.
Lau, Jesper, et al.. (2003). Parallel solid-phase synthesis of disubstituted (5-biphenyltetrazolyl) hydantoins and thiohydantoins targeting the growth hormone secretagogue receptor. Bioorganic & Medicinal Chemistry Letters. 14(2). 317–320. 17 indexed citations
7.
Bury, Paul S., Birgit Sehested Hansen, Susan M. Thorpe, et al.. (2002). Synthesis and biological evaluation of novel thio-substituted chromanes as high-affinity partial agonists for the estrogen receptor. Bioorganic & Medicinal Chemistry Letters. 12(1). 17–19. 6 indexed citations
8.
Bury, Paul S., Poul Jacobsen, Anker Jørgensen, et al.. (2002). Synthesis and pharmacological evaluation of novel cis-3,4-Diaryl-hydroxychromanes as high affinity partial agonists for the estrogen receptor. Bioorganic & Medicinal Chemistry. 10(1). 125–145. 22 indexed citations
9.
Peschke, Bernd, Michael Ankersen, Michael Bauer, et al.. (2002). The influence of conformational restriction in the C-terminus of growth hormone secretagogues on their potency. European Journal of Medicinal Chemistry. 37(6). 487–501. 7 indexed citations
10.
Hansen, Thomas K., Michael Ankersen, Kirsten Raun, & Birgit Sehested Hansen. (2001). Highly potent growth hormone secretagogues: Hybrids of NN703 and ipamorelin. Bioorganic & Medicinal Chemistry Letters. 11(14). 1915–1918. 7 indexed citations
11.
Müller, Kerstin, Ger van Zandbergen, Birgit Sehested Hansen, et al.. (2001). Chemokines, natural killer cells and granulocytes in the early course of Leishmania major infection in mice. Medical Microbiology and Immunology. 190(1-2). 73–76. 117 indexed citations
12.
Tullin, Søren, et al.. (2000). Adenosine Is an Agonist of the Growth Hormone Secretagogue Receptor. Endocrinology. 141(9). 3397–3402. 55 indexed citations
13.
Ankersen, Michael, Karin Kramer Nielsen, Thomas Kruse Hansen, Kirsten Raun, & Birgit Sehested Hansen. (2000). Growth hormone secretagogues derived from NN703 with hydrazidesas c-terminal. European Journal of Medicinal Chemistry. 35(5). 487–497. 15 indexed citations
14.
Drewes, Asbjørn Mohr, et al.. (1998). Sleep in rheumatoid arthritis: a comparison with healthy subjects and studies of sleep/wake interactions. Lara D. Veeken. 37(1). 71–81. 136 indexed citations
15.
Raun, Kirsten, Birgit Sehested Hansen, Niklas Dyrby Johansen, et al.. (1998). Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology. 139(5). 552–561. 79 indexed citations
16.
Ankersen, Michael, Bernd Peschke, Birgit Sehested Hansen, & Thomas Kruse Hansen. (1997). INVESTIGATION OF BIOISOSTERS OF THE GROWTH HORMONE SECRETAGOGUE L-692,429.. Bioorganic & Medicinal Chemistry Letters. 7(10). 1293–1298. 42 indexed citations
17.
Hansen, Birgit Sehested, J. Fogh, Uffe Birk Jensen, et al.. (1994). Gene Transfer into Cultured Human Epidermis and its Transplantation onto Immunodeficient Mice: An Experimental Model for Somatic Gene Therapy. Journal of Investigative Dermatology. 103(3). 391–394. 38 indexed citations
18.
Thomsen, Mads Krogsgaard, Christian Friis, Birgit Sehested Hansen, et al.. (1994). Studies on the Renal Kinetics of Growth Hormone (GH) and on the GH Receptor and Related Effects in Animals. Journal of Pediatric Endocrinology and Metabolism. 7(2). 93–105. 12 indexed citations
19.
Mølvig, Jens, Birgit Sehested Hansen, H. WORSAAE, et al.. (1990). Comparison of Biological and Immunological Activities of Human Monocyte‐Derived Interleukin 1β and Human Recombinant Interleukin 1β. Scandinavian Journal of Immunology. 31(2). 225–235. 12 indexed citations
20.
Helqvist, Steffen, et al.. (1989). Interleukin 1 induces new protein formation in isolated rat islets of Langerhans. European Journal of Endocrinology. 121(1). 136–140. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Glen E. Mott Breakdown of academic impact, for papers by Freek G. Bouwman Breakdown of academic impact, for papers by Ying He Breakdown of academic impact, for papers by Yue Yin Breakdown of academic impact, for papers by J. T. Fleming Breakdown of academic impact, for papers by Candace M. Cham Breakdown of academic impact, for papers by Kazuki Mochizuki Breakdown of academic impact, for papers by M. Pilar Lostao Breakdown of academic impact, for papers by Guoyao Wu Breakdown of academic impact, for papers by Yu‐Cai Fu
Rankless by CCL
2026